Inherited metabolic diseases affecting the carrier

The objective of this review is to draw attention to those inherited metabolic traits which are potentially harmful also for the carrier, and to outline preventive measures, at least for obligate heterozygotes, i.e. parents of homozygous children. Concerning carriers of food-dependent abnormalities, early vascular disease in homocystinuria, hyperammonaemic episodes in ornithine transcarbamylase deficiency, presenile cataracts in galactosaemia as well as galactokinase deficiency, spastic paraparesis in X-linked adrenoleukodystrophy, and HELLP syndrome in mothers of babies with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency have to be mentioned. In the group of food-independent disorders, clinical features in carriers may be paraesthesias and corneal dystrophy in Fabry disease, lens clouding in Lowe syndrome, lung and/or liver diseases in α1-antitrypsin deficiency, and renal stones in cystinuria type II and III. Finally, two monogenic carrier states are known which in pregnant indi-viduals could possibly afflict the developing fetus, i.e. heterozygosity for galactosaemia and for phenylketonuria. Elevated levels of galactose-1-phosphate have been found in red blood cells of infants heterozygous for galactosaemia born to heterozygous mothers. Aspartame in very high doses is reported to increase blood phenylalanine levels in heterozygotes for phenylketonuria, thus being a risk for the fetus of a heterozygous mother. For some of these carrier states preventive measures can be recommended, e.g. restriction of lactose in parents and heterozygous grandparents of children with galactosaemia and galactokinase deficiency as well as transiently in infants heterozygous for galactosaemia, dietary supplementation with monounsaturated fatty acids in symptomatic carriers for X-linked adrenoleukodystrophy, avoidance of smoking and alcohol in heterozygotes for α1-antitrypsin deficiency, avoidance of episodes of dehydration in heterozygotes for cystinuria, and restriction of aspartame in p regnant women.

[1]  S. S. Kang,et al.  Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. , 1988, American journal of human genetics.

[2]  K. Pettigrew,et al.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency. , 1985, American journal of human genetics.

[3]  J. Clarke,et al.  Maternal phenylketonuria (PKU)--a review. , 1987, Clinical biochemistry.

[4]  S. Brusilow.  Urea cycle enzymes , 2001 .

[5]  J. Carlsson.  Chronic cryptogenic liver disease and malignant hepatoma in intermediate α1-antitrypsin deficiency identified by a PiZ-specific monoclonal antibody , 1985 .

[6]  P. Manowitz,et al.  Neuropsychological deficits in obligatory heterozygotes for metachromatic leukodystrophy , 1988, Human Genetics.

[7]  L. Filer,et al.  Plasma phenylalanine levels in phenylketonuric heterozygous and normal adults administered aspartame at 34 mg/kg body weight. , 1981, Toxicology.

[8]  J. Śanchez-Corona,et al.  Red blood cell sorbitol dehydrogenase deficiency in a family with cataracts , 2004, Human Genetics.

[9]  D. Rosenblatt,et al.  Detection of heterozygotes for recessive alleles. Homocyst(e)inemia: paradigm of pitfalls in phenotypes. , 1990, American journal of medical genetics.

[10]  G. Rosa,et al.  HIGH FREQUENCY OF LACTOSE ABSORBERS AMONG ADULTS WITH IDIOPATHIC SENILE AND PRESENILE CATARACT IN A POPULATION WITH A HIGH PREVALENCE OF PRIMARY ADULT LACTOSE MALABSORPTION , 1984, The Lancet.

[11]  S. Bessman,et al.  Relationship between phenylalanine tolerance and psychological characteristics of phenylketonuric families. , 1985, Biochemical medicine.

[12]  V. Ramesh,et al.  Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. , 1993, Human molecular genetics.

[13]  J. Kraus,et al.  Screening for mutations by expressing patient cDNA segments in E. coli: Homocystinuria due to cystathionine β‐synthase deficiency , 1992, Human Mutation.

[14]  S. S. Kang,et al.  Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. , 1988, Metabolism: clinical and experimental.

[15]  K. Pittschieler.  Liver Disease and Heterozygous Alpha‐1‐Antitrypsin Deficiency , 1991, Acta paediatrica Scandinavica.

[16]  J. Harley,et al.  Maternal enzymes of galactose metabolism and the "inexplicable" infantile cataract. , 1974, Lancet.

[17]  R. Giugliani,et al.  Heterozygous cystinuria and urinary lithiasis. , 1985, American journal of medical genetics.

[18]  M. Camilleri,et al.  Pseudodominant transmission of fructose intolerance in an adult and three offspring: Heterozygote detection by intestinal biopsy. , 1982, The New England journal of medicine.

[19]  L. Holmes,et al.  Lowe's syndrome: a search or the carrier state. , 1969, Pediatrics.

[20]  L. Filer,et al.  Effect of an abuse dose of aspartame upon plasma and erythrocyte levels of amino acids in phenylketonuric heterozygous and normal adults. , 1980, The Journal of nutrition.

[21]  S. Mudd.  Disorders of transsulfuration , 1989 .

[22]  R. Clarke,et al.  Hyperhomocysteinemia: an independent risk factor for vascular disease. , 1991, The New England journal of medicine.

[23]  S. Bessman,et al.  Relative inability of mother and child to convert phenylalanine of tyrosine--a possible cause of nonspecific mental retardation. , 1979, Biochemical medicine.

[24]  G. Feldmann,et al.  HETEROZYGOUS ALPHA1-ANTITRYPSIN DEFICIENCY AND CIRRHOSIS IN ADULTS, A FORTUITOUS ASSOCIATION , 1975, The Lancet.

[25]  Danopoulos Ed,et al.  Letter: Urea treatment of skin malignancies. , 1974 .

[26]  S. Dimauro,et al.  McArdle's disease in two generations , 1987, Neurology.

[27]  G. Addison.  The Metabolic and Molecular Bases of Inherited Disease CD-ROM (Version 1.0) Edited by C.R. Scriver, A.L. Beaudet, W.S. Sly and D. Valle , 1997, Journal of Inherited Metabolic Disease.

[28]  P. Lutz,et al.  Study design and description of patients , 2005, European Journal of Pediatrics.

[29]  I. Slotki,et al.  ACUTE-ON-CHRONIC RENAL FAILURE PRECIPITATED BY CLOFIBRATE , 1976, The Lancet.

[30]  L. Mcdonald,et al.  HOMOCYSTINURIA, THROMBOSIS, AND THE BLOOD-PLATELETS. , 1964, Lancet.

[31]  H. Levy,et al.  A derangement in B 12 metabolism leading to homocystinemia, cystathioninemia and methylmalonic aciduria. , 1969, Biochemical and biophysical research communications.

[32]  S. Tsuji.  [Alpha-galactosidase A deficiency--Fabry's disease]. , 1988, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[33]  J. Hardebo,et al.  Moderate Homocysteinemia - A Possible Risk Factor For Arteriosclerotic Cerebrovascular Disease , 1984, Stroke.

[34]  W. Endres,et al.  Cataract and metabolic disease , 1990, Journal of Inherited Metabolic Disease.

[35]  G. Andria,et al.  A simplified test to detect PKU heterozygotes by discriminant analysis in mentally retarded children and their mothers , 1988, Clinical genetics.

[36]  K. Betke,et al.  Biochemical, psychometric, and neuropsychological studies in heterozygotes for various lipidoses , 1980, Human Genetics.

[37]  K. Betke,et al.  Biochemical, genetic, psychometric, and neuropsychological studies in heterozygotes of a family with globoid cell leucodystrophy (Krabbe's disease) , 2004, Human Genetics.

[38]  C. Boyd,et al.  Transport of amino acids by the human placenta: Predicted effects thereon of maternal hyperphenylalaninaemia , 1990, Journal of Inherited Metabolic Disease.

[39]  N. Blau,et al.  Effect of high-protein meal plus aspartame ingestion on plasma phenylalanine concentrations in obligate heterozygotes for phenylketonuria. , 1994, Metabolism: clinical and experimental.

[40]  F. Lindgärde,et al.  Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency. , 1988, Metabolism: clinical and experimental.

[41]  H. M. Hittner,et al.  Linkage studies in carriers of Lowe oculo-cerebro-renal syndrome. , 1982, American journal of human genetics.

[42]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[43]  J. Carlson,et al.  Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody. , 1985, Scandinavian journal of gastroenterology.

[44]  F. Patrone,et al.  Neutropenia and impaired neutrophil function in glycogenosis type Ib , 1984, Journal of Inherited Metabolic Disease.

[45]  H. Bock,et al.  Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. , 1991, American journal of human genetics.

[46]  P. Watkins,et al.  Adrenoleukodystrophy , 1986, Neurology.

[47]  C. Adamsbaum,et al.  A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy. , 1993, The New England journal of medicine.

[48]  S. Bessman.  Genetic failure of fetal amino acid "justification": a common basis for many forms of metabolic, nutritional, and "nonspecific" mental retardation. , 1972, The Journal of pediatrics.

[49]  J. Mandel,et al.  Adrénoleucodystrophie liée à l'X , 2007 .

[50]  E. Beutler,et al.  Cataracts, galactosuria and hypergalactosemia due to galactokinase deficiency in a child. Studies of a kindred. , 1971, The American journal of medicine.

[51]  M. O'Keefe,et al.  Cataracts in children with classical galactosaemia and in their parents , 1988, Journal of Inherited Metabolic Disease.

[52]  R. Gardner,et al.  Lowe's syndrome: identification of carriers by lens examination. , 1976, Journal of medical genetics.

[53]  S. Brusilow,et al.  Hyperammonemia in women with a mutation at the ornithine carbamoyltransferase locus. A cause of postpartum coma. , 1990, The New England journal of medicine.

[54]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[55]  S. Eriksson,et al.  Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function. , 1985, European journal of respiratory diseases.

[56]  E. Beutler,et al.  Galactokinase deficiency as a cause of cataracts. , 1973, The New England journal of medicine.

[57]  Debenham Gp.  HEALTH AND SOCIAL CLASS. , 1965 .

[58]  R. Wurtman,et al.  Plasma amino acid levels after single-dose aspartame consumption in phenylketonuria, mild hyperphenylalaninemia, and heterozygous state for phenylketonuria. , 1986, The Journal of pediatrics.

[59]  H. Ostrer,et al.  Prenatal diagnosis and carrier detection of genetic diseases by analysis of deoxyribonucleic acid. , 1988, The Journal of pediatrics.

[60]  S. Brusilow,et al.  Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women. , 1990, The New England journal of medicine.

[61]  S. Mudd.  Vascular disease and homocysteine metabolism. , 1985, The New England journal of medicine.

[62]  S. Bessman,et al.  The justification theory: the essential nature of the non-essential amino acids. , 2009, Nutrition reviews.

[63]  J. Berman,et al.  PHENYLALANINE METABOLISM AND INTELLECTUAL FUNCTIONING AMONG CARRIERS OF PHENYLKETONURIA AND HYPERPHENYLALANINÆMIA , 1977, The Lancet.

[64]  J. Leonard,et al.  Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency , 1993, The Lancet.

[65]  H. Skalka,et al.  ASSOCIATION OF PRESENILE CATARACTS WITH HETEROZYGOSITY FOR GALACTOSÆMIC STATES AND WITH RIBOFLAVIN DEFICIENCY , 1978, The Lancet.

[66]  W. Endres,et al.  Cataract in a fetus at risk for oculo-cerebro-renal syndrome (lowe) , 1977, Klinische Wochenschrift.

[67]  S. Brusilow,et al.  Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency. , 1980, The New England journal of medicine.

[68]  D. Wilcken,et al.  Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria. , 1983, Metabolism: clinical and experimental.

[69]  W. Endres,et al.  Sorbitol dehydrogenase deficiency in a family with congenital cataracts. , 1984, Journal of inherited metabolic disease.

[70]  R. Gitzelmann,et al.  A case of fatal hereditary fructose intolerance. Misleading information of formula composition. , 1981, Helvetica paediatrica acta.

[71]  H. Moser.  Adrenoleukodystrophy: phenotypic variability and implications for therapy , 1992, Journal of Inherited Metabolic Disease.

[72]  C. Larsson,et al.  Smoking and intermediate alpha1-antitrypsin deficiency and lung function in middle-aged men. , 1977, British medical journal.

[73]  R. Havlik,et al.  A study of cardiovascular risk in heterozygotes for homocystinuria. , 1981, American journal of human genetics.

[74]  R. Koch,et al.  Diet, genetics, and mental retardation interaction between phenylketonuric heterozygous mother and fetus to produce nonspecific diminution of IQ: evidence in support of the justification hypothesis. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[75]  W. Endres,et al.  Plasma polyol levels in patients with cataract , 1990, Journal of Inherited Metabolic Disease.

[76]  W. Rizzo,et al.  Dietary erucic acid therapy for X‐linked adrenoleukodystrophy , 1989, Neurology.

[77]  E. Beutler,et al.  GALACTOKINASE AND CATARACTS , 1978, The Lancet.

[78]  A. Fielder,et al.  Direct and maternal aspects of the risk of cataract with partial disorders of galactose metabolism , 1985, Clinical genetics.

[79]  R. Korneluk,et al.  False positive results from the alanine loading test for ornithine carbamoyltransferase deficiency heterozygosity. , 1989, The Journal of pediatrics.